Introduction
============

*Mycoplasma hyopneumoniae* is the principal aetiological agent responsible for enzootic pneumonia (EP) in pigs. Other pathogens such as *Pasteurella multocida*, *Actinobacillus pleuroneumoniae*, *Mycoplasma hyorhinis*, *Streptococcus suis*, *Haemophilus parasuis*, *Bordetella bronchiseptica* and *Arcanobacterium pyogenes* are also frequently involved ([@bib99]). The disease is characterised by high morbidity and low mortality and although pigs of all ages are susceptible to *M. hyopneumoniae* infection, EP is usually not observed in animals younger than 6 weeks of age. The prevalence of EP is particularly high in animals of mid-finishing to slaughter age and the severity of clinical signs is dictated by the strain of *M. hyopneumoniae* involved, infection pressure, the presence of secondary infections and by environmental conditions. When *M. hyopneumoniae* infection is not complicated by concomitant pathogens, the disease can take a subclinical course with mild clinical signs consisting of chronic, non-productive cough, reduced rate of average daily weight gain (ADWG) and reduced feed conversion efficiency. When secondary pathogens are involved, clinical signs include laboured breathing and pyrexia, and deaths may occur ([@bib52]).

*M. hyopneumoniae* is intimately involved in the pathogenesis of porcine respiratory disease complex (PRDC), a disease involving both bacterial (those potentially involved in EP listed above) and viral (porcine reproductive and respiratory syndrome virus \[PRRSV\], porcine circovirus type 2, Aujeszky's disease virus, swine influenza viruses \[SIVs\] and porcine respiratory coronavirus) pathogens. Porcine respiratory disease complex typically affects finishing pigs of between 14 and 20 weeks of age and is characterised clinically by depressed growth rate and feed conversion efficiency and by anorexia, fever, cough, and dyspnoea. This disease has been referred to as the '18 week wall' given its higher prevalence in pigs of this age ([@bib23]).

Although improved management methods and the judicious use of medication and vaccination have greatly alleviated the detrimental effects of EP on herd health and on carcass quality, EP-associated economic losses remain important within pig production worldwide ([@bib99]). These losses are mainly due to decreased ADWG, increased feed conversion ratio, increased medication costs and, in some cases, to higher mortality rates ([@bib53]). No recent estimates of the financial losses attributable to EP are available and these are likely to vary considerably between herds ([@bib53]).

A sound knowledge of the routes of transmission of *M. hyopneumoniae* and of the other pathogens associated with EP is necessary to control the disease as well as to understand the factors that influence the pathogenesis. In the next sections we review current knowledge of *M. hyopneumoniae* transmission and seroconversion dynamics in different swine production systems and compare the different epidemiological tools used to monitor EP. The existence of *M. hyopneumoniae* strains with different virulence characteristics and the molecular techniques available to detect them are also discussed.

Epidemiological and diagnostic tools to assess *M. hyopneumoniae* infection
===========================================================================

The investigation and control of infectious disease is critically dependent on the availability of appropriate diagnostic tools. Several diagnostic methodologies are used to monitor *M. hyopneumoniae* infection.

Clinical signs
--------------

The main clinical sign of EP is the gradual onset of a chronic, non-productive cough, particularly in pigs at the finishing stage of the production cycle. Co-infection with the additional pathogens detailed previously results in fever, anorexia and laboured breathing. The onset of coughing, although gradual, can be inconsistent and of variable intensity depending on the infecting dose of *M. hyopneumoniae*. To identify pigs with non-productive coughs, animals need to be observed over a considerable time-span and should be encouraged to move. Quantifying the number of coughing pigs in a given period of time (the 'coughing score') has been used in transmission ([@bib62], [@bib56]) and pathogenesis studies ([@bib67], [@bib106]) and has also been used in the assessment of the efficacy of *M. hyopneumoniae* vaccines under both natural ([@bib54], [@bib65]) and experimental ([@bib100]) conditions. However, given the lack of diagnostic specificity of coughing and that subclinically affected pigs would not display it, additional diagnostic modalities are required.

Abattoir surveillance
---------------------

The assessment of respiratory disease within a pig herd by lung 'lesion scoring' at abattoir inspection is frequently used to estimate the incidence of EP and its impact on carcass market price. It has been estimated that the lungs of at least 30 animals should be examined to provide a reliable measure of the prevalence and severity of the pneumonia at herd level ([@bib21]). Such surveillance may also be useful in detecting subclinical disease which can adversely affect production during the fattening period. However EP lesions are not pathognomonic of *M. hyopneumoniae* infection as other organisms such as SIV can produce similar lesions ([@bib101]).

Retrospective evaluation of the prevalence of EP in a herd by abattoir surveillance is limited in that this approach only identifies chronic lung lesions at the end of the production period and does not provide information regarding the ongoing respiratory health of the pigs during fattening ([@bib71]). Similarly, the presence of additional bacterial pathogens such as *A. pleuropneumoniae* can cause severe pleuritis that mask EP lesions. Lesion resolution may lead to false-negative results or to an equivocal diagnosis of early mycoplasmosis ([@bib89]). The scoring systems used most frequently in EP abattoir surveillance are summarised in [Table 1](#tbl1){ref-type="table"} . The subjectivity involved in the visual estimation of the proportion of lung consolidated and the lack of diagnostic specificity of these lesions, limit abattoir surveillance as a diagnostic approach and, therefore, the use of additional confirmatory methods is needed.Table 1Summary of scoring systems used in the abattoir surveillance of enzootic pneumoniaReferenceScoring unitMultiplying factor: Relative weight of each lobeMaximum total scoreApicalMiddleDiaphragmaticAccessoryRightLeftRightLeftRightLeft[@bib36]1--5 points per lobe5/75/75/75/75/195/195/835[@bib50]1--4 points per lobe depending on percentage of lobe affected0 points = no lesions; 1 point = \<25% of lobe; 2 points = 25--49%; 3 points = 50--74%; and 4 points \>75%. Points for each of the seven lobes.28[@bib69]Percentage of lobe affected10107730306100[@bib98]Percentage of lobe affected10101010252510100[@bib20]Percentage of lobe affected7415935255100

Bacteriological culture
-----------------------

The isolation of *M. hyopneumoniae* from affected lungs by bacteriological culture is considered the 'gold standard' diagnostic technique ([@bib99]) but isolation of the pathogen requires specialised Friis medium. [@bib89] compared the detection of *M. hyopneumoniae* by culture, immunofluorescence assay (IFA), enzyme-linked immunosorbent assay (ELISA) and by a polymerase chain reaction (PCR) method and found culture the most sensitive technique particularly at the later stages of EP when fewer mycoplasma organisms were present. However, *M. hyopneumoniae* culture is laborious, time-consuming (isolation from field samples requires 4--8 weeks) and frequently culture media can become overgrown with *M. hyorhinis* or *M. flocculare* ([@bib52]).

Serological detection of *M. hyopneumoniae* infection
-----------------------------------------------------

Serological tests are commonly used to monitor the health status of pig herds. Detection of antibodies to *M. hyopneumoniae* can be accomplished by ELISA and, less frequently, by complement fixation test. Antibody profiling of pig herds requires the simultaneous testing of groups of animals of different ages (transversal study) or the testing of one group of animals throughout the production cycle (longitudinal study) by ELISA. The ELISA in this context is a rapid, inexpensive and easily automated method that provides useful information on the presence of maternally-derived and acquired antibodies, as well as on the time required for animals to seroconvert. A blocking ELISA (IDEI, *Mycoplasma hyopneumoniae* EIA kit, Oxoid) and two indirect ELISA tests (HerdCheck, IDEXX and Tween 20-ELISA) are the most frequently used serological tests to detect antibodies to *M. hyopneumoniae*. Comparative studies have reported differing specificities and sensitivities between these kits ([@bib76], [@bib97], [@bib2], [@bib26]). When discrepancies in serological test results are identified, a Western blot immunoassay (WBI) targeting different *M. hyopneumoniae* antigens can be used as a confirmatory test ([@bib1]). The utility of antibody profiling can be hindered by: variation in ELISA results depending on the test used ([@bib2], [@bib26]); the inability of serology to differentiate natural infection from vaccination; lack of correlation between different measures of antibody titre; variations in the detection of antibodies to different strains of *M. hyopneumoniae* ([@bib97]); significant variability in the time taken by animals to seroconvert.

Seroconversion under natural conditions is slower than in experimental studies. Although antibodies were detected 2--4 weeks after intratracheal infection of pigs with *M. hyopneumoniae* ([@bib83], [@bib42]). [@bib89] reported seroconversion as early as 8 days post-infection (PI) in a proportion of pigs infected by aerosol, although the remaining animals required five further weeks to seroconvert. Under natural conditions, [@bib68] detected seroconversion in a herd 3 weeks after contact exposure, with titres peaking around 11 weeks after exposure. In two other studies carried out under field conditions, seroconversion occurred mainly in grower-finishing units (8--24 weeks of age), between 6 and 9 weeks PI ([@bib3], [@bib48]). The delay in seroconversion associated with infection with this pathogen may partly be due to the fact that *M. hyopneumoniae* attaches to the ciliated respiratory epithelium and does not invade the pulmonary tissue to the same extent as other pathogens. This may result in slower presentation of mycoplasma antigens to the host. Of further note is the fact that there is no correlation between antibody titres and protection against the infection ([@bib52]).

Detection of *M. hyopneumoniae* antigen
---------------------------------------

Although immunohistochemistry (IHC) and IFA specifically detect *M. hyopneumoniae* in lung tissue sections or smears, these techniques have the drawback that a diagnosis can only be made post-mortem. Moreover, only a small lung sample is tested when using these techniques, increasing the risk of a false-negative result if airway is not included in the sample ([@bib12]). Furthermore, test sensitivity may be compromised by improper tissue processing. The quality of the antibodies used in these methods may also limit specific detection given that polyclonal antibodies may link with other, closely related, *Mycoplasma* spp. ([@bib19]).

Although IHC using monoclonal or polyclonal antibodies specific to *M. hyopneumoniae* on formalin-fixed, paraffin-embedded lung sections allows the pathologist to correlate the presence of mycoplasma antigen with EP lesions ([@bib82], [@bib78]), the technique is not routinely used in diagnostic laboratories due to its limited sensitivity. Direct ([@bib41]) and indirect IFAs ([@bib75]) have been used to localise *M. hyopneumoniae* antigen in porcine lungs. The IFA has also been compared with PCR as a diagnostic technique in pathogenesis and transmission studies ([@bib89], [@bib106], [@bib62]). A positive IFA test is associated with the more acute stage of EP when the mycoplasmal load is high, in contrast with the low sensitivity of this assay in more chronic disease when lower numbers of mycoplasma organisms are likely to be present ([@bib79]). A further limitation of the IFA is that in the frozen tissue sections used, artefactual tissue fragmentation may obscure morphological features.

Molecular detection methods
---------------------------

### *In situ* hybridisation

*In situ* hybridization (ISH) has been used to detect and specifically locate *M. hyopneumoniae* DNA in formalin-fixed, paraffin-embedded lung tissue of naturally ([@bib45]) and experimentally infected pigs ([@bib46]). This technique uses a digoxigenin-labelled specific probe targeting a repetitive sequence of the *M. hyopneumoniae* genome. A fluorescent oligonucleotide probe targeting 16S ribosomal DNA has also been used for species-specific identification of *M. hyopneumoniae*, *M. hyosynoviae*, and *M. hyorhinis* ([@bib11]). Drawbacks of this method are that it requires post-mortem samples and it is relatively time-consuming and therefore not suitable for rapid diagnosis.

Polymerase chain reaction
-------------------------

Several PCR techniques for *M. hyopneumoniae* DNA detection in different sample types have been described ([Table 2](#tbl2){ref-type="table"} ). These PCR methods are more rapid than bacteriological culture and are relatively inexpensive to perform ([@bib14]). However the confounding significance of sample contamination is much higher with PCR. Given that *M. hyopneumoniae* DNA from both live and dead organisms is amplified, the identification of PCR positive animals raises the question of whether such pigs have active infection or not. Since *M. hyopneumoniae* attaches to the ciliated epithelium of the airways, the best samples to detect *M. hyopneumoniae* by PCR are tracheo-bronchial swabs or bronchoalveolar lavage fluid (BALF). Tracheo-bronchial swabs and BALF are equally predictive of infection in both live ([@bib56]) and dead ([@bib44]) experimentally infected pigs. The use of PCR to detect *M. hyopneumoniae* in lung tissue has produced variable results. [@bib64] suggested that lung samples are more appropriate than BALF in cases of moderate to severe EP, whereas [@bib44] found lung tissue unreliable in this context.Table 2Summary of reported PCR-based techniques used to detect *M. hyopneumoniae*ReferenceType of PCRAmpliconThreshold of detectionClinical samples testedGeneLength (bp)[@bib37]SRepeated unknown sequence5205 ng or 1000 CFU/mLNone[@bib5]SUnique hypothetical gene4561--10 pg of DNABALF, lung tissue[@bib96]S16 SrRNA2001000 genomeNone[@bib57]S16 SrRNA6495 CFUNasal swab[@bib9]SPutative ABC transporter1561500 fgTracheo-bronchial lavage[@bib95]NMHYP1-03-950 repetitive element8081 cell/filterFiltered air sample[@bib8]SNot given853100 CFU/mLBALF[@bib14]N16SrRNA35280 cellsNasal swab[@bib104]NPutative ABC transporter7061 fgTracheo-bronchial lavage, nasal swab[@bib18]SIntergenic sequence (p36)94850 pgLung tissue, tracheo-bronchial lavage Nasal swabSIntergenic sequence (p46)5800.5 ngMp36 and p46948 and 580Not given[@bib44]NUnique hypothetical gene2400-5-1 fgTracheo-bronchial brushes, BALF[@bib25]RTMHYP1-03-950 repeated element8081 fgBronchial swabsI-141 fragment putative ABC transporter7061 fg[@bib93]M16SrRNA10001 pgNone[@bib12]S16SrRNA6490.18 CFU/gLung tissue[^1]

Ideally, a test to detect the presence of a pathogen in a living animal should be easy to perform, rapid, inexpensive, and should provide data of use in the implementation of control measures. Although the detection of *M. hyopneumoniae* in the nasal cavities of living pigs by PCR might theoretically fit these criteria, pigs inoculated with *M. hyopneumoniae* intratracheally were found to have low numbers of organisms in their upper respiratory tract and only shed the organism intermittently ([@bib44], [@bib80], [@bib73]). However, the use of PCR to diagnose natural infection from nasal swabs was found reliable and an association was found between the detection of *M. hyopneumoniae* in the nasal cavities and bronchi with lesions of EP ([@bib84]). Although the potential use of nasal swabs for nested PCR (nPCR) testing for *M. hyopneumoniae* in live pigs has been demonstrated ([@bib87]), the procedure is currently considered more useful for the monitoring of infection at a herd rather than at an individual animal level ([@bib72]).

The detection of *M. hyopneumoniae* by PCR provides a more precise method of determining when animals become infected that using time for seroconversion to occur, as this may vary considerably ([@bib68], [@bib3], [@bib48]).

Molecular typing techniques
---------------------------

Variations in the clinical course of EP ([@bib105]) and inconsistencies in the efficacy of vaccination have raised suspicions that *M. hyopneumoniae* isolates vary in virulence. Differences at the antigenic ([@bib6]), chromosomal ([@bib32], [@bib91]), genomic ([@bib49], [@bib63], [@bib51], [@bib58]) and proteomic ([@bib16]) levels have been reported between *M. hyopneumoniae* isolates and, finally [@bib106] demonstrated differing virulence characteristics between such isolates. Differences in adhesion ([@bib22]) and transmission ([@bib61], [@bib56]) of the organism have been suggested but not clearly demonstrated.

From an epidemiological perspective, typing *M. hyopneumoniae* isolates would facilitate the understanding of the transmission of *M. hyopneumoniae* isolates within and between herds. Recently described molecular typing techniques ([Table 3](#tbl3){ref-type="table"} ) suggest that one strain of *M. hyopneumoniae* infects a given herd, whereas the strains involved in different outbreaks vary ([@bib91], [@bib59]).Table 3Summary of molecular techniques used to genotype *M. hyopneumoniae* field strains (adapted from [@bib90])Target of techniqueMethodologyTechnique(s) usedReferenceAmpliconReproducibilityDiscriminatory powerEase of performanceTime required (days)Ease of interpretationCost-efficientEntire genomeRestriction and electrophoresisFIGE[@bib32]Eco RI+++−2--3++PFGE[@bib10]ApaI, Sal I, ApaL, Asp718++++−2--3++[@bib91]Restriction and hybridisationREA and DNA specific probe[@bib31]IS-like±±++1−−−[@bib38]Unknown repetitive sequenceRestriction and PCRAFLP[@bib43]Restriction enzymes+++±2−+[@bib92]PCRRAPD (AP-PCR)[@bib4]OPA-3 primer−++++\<1±−[@bib106][@bib92]  Specific DNA fragmentPCRPCR[@bib40], [@bib49]P97++−++\<1+−PCR of repetitive elementsVNTR[@bib92]P97++±++\<1+−[@bib22]VNTR genesPCR and restrictionPCR-RFLP[@bib92]P146++±++\<1+±PCR and electrophoresisPCR-DGGE[@bib60]16 SrRNAPCR and sequencingPCR-seq[@bib109]P97++++1++[@bib58]p146[@bib70]mnSSRNA+++1++MLST[@bib59]*adk, rpoB, tpiA*++++±2++PCR and hybridisationMicroarray[@bib51]*125--350 bp PCR products*++++−1−−[^2]

Transmission
============

Transmission under field conditions
-----------------------------------

*M. hyopneumoniae* may be introduced into a herd in two main ways: by direct transmission following the introduction of purchased, subclinically infected replacement gilts or other pigs; and by airborne transmission. The role of fomites is thought to be minimal ([@bib7]).

Direct transmission
-------------------

Once in the herd, *M. hyopneumoniae* is transmitted between animals in aerosolised droplets generated by coughing and sneezing or may spread through direct contact. Infection may spread horizontally from infected to naïve pigs ([@bib68]) or vertically from sows to their piglets ([@bib52]).

Vertical transmission
---------------------

Infected gilts and sows can transmit *M. hyopneumoniae* to newly introduced gilts, including vaccinated animals ([@bib74]). In addition to the introduction of such animals, the transmission dynamics also includes the ongoing infection of piglets by sows. In particular low parity sows or gilts have low levels of antibodies and excrete more mycoplasma organisms than do older sows ([@bib52], [@bib29]). However, based on a nPCR technique, it has been indicated that breeding sows from their second to seventh parity can remain persistently infected with *M. hyopneumoniae* ([@bib13]). More research is required to determine how sow parity affects the shedding of *M. hyopneumoniae* and the development of disease in their offspring

Horizontal transmission
-----------------------

Horizontal transmission of infection may occur between pen mates or, in continuous flow production systems, from older to younger animals. Moreover, airborne transmission of infection can occur between different barns or units within a herd. Once established, *M. hyopneumoniae* infection may persist in the respiratory tract of adult animals for up to 185 days ([@bib27]). Persistently infected pigs typically have subclinical disease, are difficult to detect using currently available diagnostic tools and remain carriers, capable of transmitting the pathogen to susceptible animals ([@bib80], [@bib77]).

Horizontal transmission of *M. hyopneumoniae* between wild boar and domestic pigs has recently been suggested in France ([@bib55]) and Slovenia ([@bib103]). In the former study, *M. hyopneumoniae* DNA was detected by PCR in lung homogenates of 9% of the wild boars tested. Although preliminary, these findings suggest that wild boar are a potential reservoir of *M. hyopneumoniae* infection for domestic swine or vice versa.

Airborne transmission
---------------------

Although the main source of transmission between pigs is considered to be direct contact with subclinically infected carrier animals, the spread of *M. hyopneumoniae* infection by aerosol has recently gained more significance ([@bib24]). Airborne particles containing the microorganism are generated by sneezing and coughing, and are also exhaled by infected pigs ([@bib94]). [@bib33] suggested that aerosol transmission between farms may occur and that the risk of a herd becoming infected with *M. hyopneumoniae* was inversely related to the proximity of other pig farms. [@bib110] found that a pig herd's risk of becoming infected was closely associated with pig density in the area and with the distance to neighbouring farms. The minimum distance between pig farms to theoretically avoid airborne transmission has been calculated to be at least 3 km. In Denmark, [@bib102] proposed airborne transmission as a major source of *M. hyopneumoniae* infection in mycoplasma-free SPF pig herds and indicated that the risk of these herds becoming infected was greater when neighbouring infected herds were larger.

Other transmission routes
-------------------------

Apart from direct contact and airborne transmission, indirect transmission of infection through fomites has also been suggested ([@bib33]). However an investigation by [@bib7] concluded that when standard biosecurity protocols were followed by farm personnel in weekly contact with infected pigs, *M. hyopneumoniae* was not transmitted to naïve animals.

Transmission under experimental conditions
------------------------------------------

Experimental studies have been used to study *M. hyopneumoniae* transmission and the infection dynamics between pig populations of varying infection status. To evaluate and quantify the transmission of *M. hyopneumoniae* to nursery pigs under standardised experimental conditions, [@bib61] used an adjusted reproduction ratio (*R* ~*n*~). This *R* ~*n*~ value expressed the mean number of secondary infections caused by one infectious piglet during a nursery period of 6 weeks where the virulence of the isolate was taken into account ([@bib106]). The *R* ~*n*~ values for the high and low virulent isolates were 1.47 and 0.85, respectively, although this difference was not statistically significant. These results imply that one piglet infected before weaning is able to infect one to four pen mates during the nursery period. Under the experimental conditions of this study ([@bib61]), the spread of *M. hyopneumoniae* between animals was slow. Other experimental studies have demonstrated transmission of *M. hyopneumoniae* between pen mates by 7 ([@bib56]) and 28 ([@bib28]) days PI. [@bib27] reported directly and indirectly in-contact animals seroconverting 5 and 6 weeks later than experimentally inoculated pigs.

[@bib62] demonstrated that vaccination, with a commercially available vaccine, did not significantly reduce *M. hyopneumoniae* transmission with *R* ~*n*~ values of 2.38 and 3.51 in vaccinated and non-vaccinated animals, respectively. This finding confirms what has been observed in several field studies, that the number of vaccinated seropositive pigs gradually increases towards the end of the finishing period, indicating that *M. hyopneumoniae* can still circulate in vaccinated animals ([@bib54]).

Few experimental studies have focused on the airborne transmission of *M. hyopneumoniae*. [@bib28] reported the transmission of *M. hyopneumoniae* via aerosol to sentinel pigs located in a trailer 6 m from pigs experimentally co-infected with *M. hyopneumoniae* and PRRSV. Three weeks after exposure, 4/10 sentinel animals were positive for *M. hyopneumoniae* by nPCR in nasal and bronchial swabs and exhibited microscopic lesions suggestive of EP. [@bib17] detected *M. hyopneumoniae* DNA in air samples 1, 75 and 150 m from where the microorganism was aerosolised. Although the movement of *M. hyopneumoniae* by aerosol was demonstrated in this study, the capacity of this aerosol to successfully infect pigs was not.

[@bib80] demonstrated different infection patterns among pigs sired by different boars suggesting a possible genetic component to the susceptibility of animals to *M. hyopneumoniae* infection. However, the small sample of animals studied and the fact that the role of sow genetics was not assessed, limited the conclusions that could be drawn.

Herd epidemiology: Infection and seroconversion dynamics
========================================================

The clinical outcome of *M. hyopneumoniae* infection is dependent on environmental and management conditions and on the production system in operation. Among the various management conditions, all-in--all-out (AIAO) procedures may help in reducing the prevalence and severity of EP lesions ([@bib52]). In farrow-to-finish (FF) systems, in which piglets remain until slaughter, transmission of infection from sows to piglets and from older to younger pigs occurs. In contrast, in multi-site (MS) systems the stages of pig production are physically separated from each other and the 'flow' of animals is unidirectional ([@bib39]). In both systems the reproductive herd comprises animals of different ages and of different physiologic status (i.e. breeding, gestation, farrowing and lactation) and new animals are introduced to this group on an ongoing basis.

There is little information on the prevalence of *M. hyopneumoniae*-infected sows or their potential to shed bacteria and infect their offspring. [@bib13] reported that between 24% and 56% of non-vaccinated sows were positive for *M. hyopneumoniae* by nPCR in a MS system. However, [@bib81], [@bib88] found a lower percentage (between 0% and 10.5%) of *M. hyopneumoniae*-infected sows at farrowing in both MS and FF systems. These findings also suggested that the prevalence of *M. hyopneumoniae* infection in sows was not related to the production system in operation.

In MS systems, piglets may become infected prior to weaning ([@bib34], [@bib13]). [@bib13] reported between 7.7% and 9.6% of pigs infected by 17 days of age, [@bib81] reported between 5.5% and 13.2% of piglets infected on a breeding unit at 19 days of age, and [@bib87] found between 0% and 6.4% of pigs from 1 to 3 weeks of age, infected. [@bib30] reported much higher infection rates of up to 51.8% in piglets at 17 days of age. [@bib77] hypothesised that the prevalence of porcine mycoplasma infections in segregated production systems varies according to the prevalence of *M. hyopneumoniae* infection among pigs at weaning. Moreover, prevalence of *M. hyopneumoniae* nasal infection in recently weaned pigs has been suggested as a potential indicator of shedding by sows ([@bib81]) and a possible predictor of the severity of EP in older animals ([@bib30], [@bib86], [@bib87]).

Although animals can be infected early in life in both FF and MS systems, different infection and disease pathogenesis patterns have been reported ([@bib85]). While in FF operations, infection of piglets at the nursery stage tends to be high and the percentage of infected pigs increases progressively with advancing age, this percentage in MS systems tends to decrease with age at the nursery stage and then to increase abruptly at fattening ([@bib85]), a situation mirrored in herds with PRDC ([@bib23]).

Detection of *M. hyopneumoniae* infection in a herd does not necessarily imply that this pathogen is the main causative agent of any existing respiratory problem. [@bib85] identified farms with subclinical or clinical EP depending on their *M. hyopneumoniae* nPCR profile. A farm was considered to have subclinical EP when the proportion of infected pigs at different ages was low even when coughing was present. However herds with a high and increasing proportion of *M. hyopneumoniae*-infected pigs with concomitant coughing were considered clinically affected.

Several epidemiological studies describe *M. hyopneumoniae* seroconversion dynamics ([@bib15], [@bib48], [@bib105], [@bib85], [@bib107]). Under field conditions, there is a progressive decrease in the numbers of pigs with maternal antibodies followed by a slow increase in the numbers of seropositive animals towards the finishing stage of production ([@bib15]). Although the median half-life of maternal antibody against *M. hyopneumoniae* is approximately 16 days ([@bib66]), they may persist for 9 weeks when initial titres are high ([@bib108]). Persistence of maternal antibody to *M. hyopneumoniae* in piglets is also dictated by the level of antibody in the sow's serum ([@bib108]). Within a variable time-span after maternal antibodies wane, pigs seroconvert to *M. hyopneumoniae* ([@bib89], [@bib107]) although the waning of maternal antibodies may not be as significant in *M. hyopneumoniae*-vaccinated herds ([@bib85]). The fact that the number of seropositive animals gradually increases towards the end of the fattening period in both vaccinated and non-vaccinated herds suggests that antibodies induced by either natural infection or vaccination do not prevent further infection ([@bib53], [@bib54]).

Discussion
==========

Although major efforts to control *M. hyopneumoniae* infection and its detrimental effects have been made, significant economic losses in pig production worldwide due to EP remain ([@bib99]). Effective control requires a number of actions including establishing and monitoring the extent of disease, reducing transmission of infection and developing an appropriate vaccination strategy.

Establishing and monitoring the extent of EP in pig herds now typically utilises ELISA, PCR and abattoir surveillance methods. Necropsy is also useful, particularly when accompanying PRDC is suspected. Given that each of these diagnostic techniques has the limitations outlined previously, their use in combination is required to optimise diagnostic accuracy.

Reducing *M. hyopneumoniae* transmission between animals requires particular attention to critical transmission points. At weaning, *M. hyopneumoniae*-infected piglets may transmit the agent to nursery and finishing sites. Also, by the time animals are moved from the nursery to the finishing units, many animals have low levels of maternal antibodies ([@bib48]) and are thus more susceptible to infection. Furthermore, the possibility of the airborne transmission of *M. hyopneumoniae* between farms or between production units within a herd should also be considered.

The development of an appropriate vaccination strategy may involve vaccination of piglets, sows, or both, against *M. hyopneumoniae*. Although currently available vaccines reduce the extent of EP lesions in vaccinated piglets, the vaccine does not protect animals against infection ([@bib35]). Sow vaccination can control EP by transferring colostral-derived immunity to the piglets and thus reducing vertical transmission ([@bib86]). Further studies will be required to determine the relative effectiveness of these strategies and in particular to look at the protective efficacy of vaccination against potentially more virulent field isolates.

Experimental transmission models are useful in estimating the effects of treatment and control measures on the spread of *M. hyopneumoniae* infection but the results of such work must be treated with a degree of caution as the infecting dose in experimental situations is likely to be larger than under field conditions. Such larger challenge doses may explain the more rapid seroconversion observed in experimentally relative to naturally infected animals ([@bib27]).

Although *M. hyopneumoniae* is usually considered primarily a respiratory pathogen, recent studies have reported the isolation of this agent from the liver, spleen and kidneys of experimentally ([@bib47]) and in-contact infected pigs ([@bib56]). This finding suggests that *M. hyopneumoniae* infection is not always restricted to the respiratory tract and merits further investigation.

Conclusions
===========

The effective control of *M. hyopneumoniae*-infection and of consequent EP in pig herds requires a number of actions including the establishment and monitoring of the extent of the disease, the use of techniques such as the molecular typing of isolates to analyse infection transmission patterns and the design of effective vaccines and vaccination strategies.
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[^1]: S, standard; N, nested; M, multiplex; RT, real time; BALF, bronchoalveolar lavage fluid.

[^2]: PCR, polymerase chain reaction; RAPD, randomly amplified polymorphic DNA; VNTR, variable number tandem repeats; AFLP, amplified fragment length polymorphism; RLFP, restriction fragment length polymorphism; PFGE, pulsed-field gel electrophoresis; DGGE, denaturing gradient gel electrophoresis; Seq, sequencing; REA, restriction endonuclease analysis; AP-PCR, arbitrarily primed PCR; FIGE, field-inversed gel electrophoresis; mnSSR, mononucleotide simple sequence repeats; MLST, multi locus sequence typing; NA, not available; ++, very high; +, high; ±, moderate; −, low; −−, very low.
